Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Alphamab Oncology, Alterity, Asahi Kasei, Astellas, Atea, Biothera Solutions, Boan, Canbridge, Direct Biologics, Hanmi, Immutep, Invex, Luye, Mabwell, Olipass, Pfizer, Telix, Vectivbio.